VYGR - Voyager Therapeutics gets new chief medical officer
2024-03-13 09:57:09 ET
More on Voyager Therapeutics
- Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier
- Voyager Therapeutics GAAP EPS of $1.25 beats by $1.54, revenue of $90.06M beats by $69.42M
- Voyager Therapeutics Q4 2023 Earnings Preview